Waiting
Login-Verarbeitung ...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Ved hjelp av RNA-sekvensering for å oppdage Novel …
JoVE Journal
Cancer Research

Ein Abonnement für JoVE ist erforderlich, um diesen Inhalt ansehen zu können. Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.

JoVE Journal Cancer Research
Ved hjelp av RNA-sekvensering for å oppdage Novel Splice Varianter Relatert til Drug Resistance in
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Journal (Cancer Research)
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Introducing Human Cells into a Microfluidic Device to Investigate Tumor Progression in a Vascularized Micro-Tumor System (Video) | JoVE
Journal (Cancer Research)
Introducing Human Cells into a Microfluidic Device to Investigate Tumor Progression in a Vascularized Micro-Tumor System (Video) | JoVE
 
Click here for the English version

Ved hjelp av RNA-sekvensering for å oppdage Novel Splice Varianter Relatert til Drug Resistance in

Article DOI: 10.3791/54714-v • 09:58 min • December 9th, 2016
December 9th, 2016 •
1,2,3, 1, 4, 3, 5, 6, 1,7, *1, *3,8,9
1Department of Pediatric Oncology/Hematology, VU University Medical Center, 2Department of Hematology, VU University Medical Center, 3Department of Medical Oncology, VU University Medical Center, 4Department of Clinical Genetics, VU University Medical Center, 5Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa, 6Amsterdam Immunology and Rheumatology Center, VU University Medical Center, 7Princess Máxima Center for Pediatric Oncology, 8Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, 9Institute of Nanoscience and Nanotechnology, CNR-Nano
* These authors contributed equally

Kapitel

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Her beskriver vi en protokoll for å undersøke virkningen av avvikende spleising på legemiddelresistens i solide svulster og hematologisk malignitet. Til dette målet, analyserte vi transcriptomic profiler av foreldre og resistente in vitro modeller gjennom RNA-seq og etablert en QRT-PCR basert metode for å validere kandidat gener.

Tags

Cancer Research kjemoterapi motstand cytotoksisitet alternativ spleising RNA-seq transcriptomics
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter